Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy
The DOI matches its Crossref record; 283 of the 283 references it cites were found in a registry or an index.
Abstract
PURPOSE: The Cancer Imaging Program of the National Cancer Institute convened a workshop to assess the current status of hypoxia imaging, to assess what is known about the biology of hypoxia as it relates to cancer and cancer therapy, and to define clinical scenarios in which in vivo hypoxia imaging could prove valuable. RESULTS: Hypoxia, or low oxygenation, has emerged as an important factor in tumor biology and response to cancer treatment. It has been correlated with angiogenesis, tumor aggressiveness, local recurrence, and metastasis, and it appears to be a prognostic factor for several cancers, including those of the cervix, head and neck, prostate, pancreas, and brain. The relationship between tumor oxygenation and response to radiation therapy has been well established, but hypoxia also affects and is affected by some chemotherapeutic agents. Although hypoxia is an important aspect of tumor physiology and response to treatment, the lack of simple and efficient methods to measure and image oxygenation hampers further understanding and limits their prognostic usefulness. There is no gold standard for measuring hypoxia; Eppendorf measurement of pO(2) has been used, but this method is invasive. Recent studies have focused on molecular markers of hypoxia, such as hypoxia inducible factor 1 (HIF-1) and carbonic anhydrase isozyme IX (CA-IX), and on developing noninvasive imaging techniques. CONCLUSIONS: This workshop yielded recommendations on using hypoxia measurement to identify patients who would respond best to radiation therapy, which would improve treatment planning. This represents a narrow focus, as hypoxia measurement might also prove useful in drug development and in increasing our understanding of tumor biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–283 of 283
Concurrent tirapazamine and radiotherapy for advanced head and neck carcinomas: a phase II study
Lee, D., Trotti, A., Spencer, S. A., Rostock, R. A., Fisher, C., von Roemeling, R., Harvey, E., & Groves, E. S. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00310-1 · Cited by 82
Keynote address: The influence of microenvironmental factors on the activity of radiation and drugs
Durand, R. E. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90100-i · Cited by 82
Osteopontin and colon cancer progression
Yeatman, T. J., & Chambers, A. F. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022502805474 · Cited by 80
Sealy, R. C., Swartz, H. M., & Olive, P. L. (1978) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(78)90928-2 · Cited by 80
Cvetković, D., Movsas, B., Dicker, A. P., Hanlon, A. L., Greenberg, R. E., Chapman, J. D., Hanks, G. E., & Tricoli, J. V. (2001) · Urology · doi:10.1016/s0090-4295(00)01044-x · Cited by 78
O’Hara, J. A., Goda, F., Demidenko, E., & Swartz, H. M. (1998) · Radiation Research · doi:10.2307/3579872 · Cited by 78
Osteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growth.
Médico, E., Gentile, A., Celso, C. L., Williams, T. A., Gambarotta, G., Trusolino, L., & Comoglio, P. M. (2001) · PubMed · Cited by 75
Tumour response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imaging
Robinson, S. P., Collingridge, D. R., Howe, F. A., Rodrigues, L. M., Chaplin, D. J., & Griffiths, J. R. (1999) · NMR in Biomedicine · doi:10.1002/(sici)1099-1492(199904)12:2<98::aid-nbm556>3.0.co;2-i · Cited by 75
Robinson, S. P., Rodrigues, L. M., Ojugo, A., McSheehy, P., Howe, F. A., & Griffiths, J. R. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.172 · Cited by 74
Kovacs, M. S., Hocking, D. J., Evans, J., Siim, B. G., Wouters, B. G., & Brown, J. M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690492 · Cited by 73
Magnetic resonance imaging for in vivo assessment of tissue oxygen concentration
Krishna, M. C., SUBRAMANIAN, S., Kuppusamy, P., & Mitchell, J. C. (2001) · Seminars in Radiation Oncology · doi:10.1053/srao.2001.18104 · Cited by 71
Tumor physiologic response to combretastatin A4 phosphate assessed by MRI
Zhao, D., Jiang, L., Hahn, E. W., & Mason, R. P. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.03.009 · Cited by 68
Enhanced binding of the hypoxic cell marker [3H]fluoromisonidazole in ischemic myocardium.
Martin, G. V., Caldwell, J. H., Rasey, J. S., Grünbaum, Z., Cerqueira, M. D., & Krohn, K. A. (1989) · PubMed · Cited by 67
Dorie, M. J., & Brown, J. M. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050584 · Cited by 65
Koch, C. J., Hahn, S. M., Rockwell, K., Covey, J. M., McKenna, W. G., & Evans, S. M. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100324 · Cited by 65
In vivo imaging of free radicals: Applications from mouse to man
He, G., Samouilov, A., Kuppusamy, P., & Zweier, J. L. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1015994629341 · Cited by 64
Masuda, K., Ono, M., Okamoto, M., Morikawa, W., Otsubo, M., Migita, T., Tsuneyoshi, M., Okuda, H., Shuin, T., Naito, S., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11152 · Cited by 63
Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI
Lu, Z., Parker, D. L., Goodrich, K. C., Wang, X., Dalle, J. G., & Buswell, H. R. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10656 · Cited by 63
HIF-1’s Relationship to Oxygen: Simple yet Sophisticated
Maxwell, P. H. (2004) · Cell Cycle · doi:10.4161/cc.3.2.616 · Cited by 62
Turetschek, K., Preda, A., Floyd, E., Shames, D. M., Novikov, V., Roberts, T. P. L., Wood, J. M., Fu, Y., Carter, W. O., & Brasch, R. C. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1000-5 · Cited by 62
Clark, L. C., Ackerman, J. L., Thomas, S. R., Millard, R. W., Hoffman, R. E., Pratt, R. G., Ragle-Cole, H., Kinsey, R. A., & Janakiraman, R. (1984) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-4895-5_81 · Cited by 61
Hypoxia and VEGF mRNA Expression in Human Tumors
Ziemer, L. S., Koch, C. J., Maity, A. M., Magarelli, D. P., Horan, A. D., & Evans, S. M. (2001) · Neoplasia · doi:10.1038/sj.neo.7900195 · Cited by 60
Measurements of Oxygen in Tissues: Overview and Perspectives on Methods
Swartz, H. M., & Dunn, J. F. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0075-9_1 · Cited by 59
Correlation of Tumor Oxygen Dynamics with Radiation Response of the Dunning Prostate R3327-HI Tumor1
Zhao, D., Constantinescu, A., Chang, C.-H., Hahn, E. W., & Mason, R. P. (2003) · Radiation Research · doi:10.1667/0033-7587(2003)159[0621:cotodw]2.0.co;2 · Cited by 59
Novel 1H NMR approach to quantitative tissue oximetry using hexamethyldisiloxane
Kodibagkar, V. D., Cui, W., Merritt, M. E., & Mason, R. P. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20826 · Cited by 58
Adaptation of human tumor cells to tirapazamine under aerobic conditions
Elwell, J. H., Siim, B. G., Evans, J., & Brown, J. M. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00171-8 · Cited by 57
Muscle cramping in phase i clinical trials of tirapazamine (SR 4233) with and without radiation
Doherty, N., Hancock, S., Kaye, S. B., Coleman, C. N., Shulman, L. N., Marquez, C., Mariscal, C. S., Rampling, R. P., Senan, S., & von Roemeling, R. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)90293-3 · Cited by 55
A comparison in individual murine tumors of techniques for measuring oxygen levels
Kavanagh, M.-C., Tsang, V., Chow, S., Koch, C. J., Hedley, D. W., Minkin, S., & Hill, R. P. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00104-2 · Cited by 55
Mattern, J., Kallinowski, F., Herfarth, C., & Volm, M. (1996) · International Journal of Cancer · Cited by 54
Regional Tumor Oxygenation and Measurement of Dynamic Changes
Mason, R. P., Constantinescu, A., Hunjan, S., Le, D., Hahn, E. W., Antich, P. P., Blum, C., & Peschke, P. (1999) · Radiation Research · doi:10.2307/3580323 · Cited by 54
Epstein-Barr virus induces invasion and metastasis factors.
Wakisaka, N., & Pagano, J. S. (2003) · PubMed · Cited by 53
Zhao, D., Constantinescu, A., Hahn, E. W., & Mason, R. P. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)156[0510:todwrt]2.0.co;2 · Cited by 53
Dunst, J., Stadler, P. F., Becker, A., Kuhnt, T., Lautenschläger, C., Molls, M., & Haensgen, G. (2001) · Strahlentherapie und Onkologie · doi:10.1007/pl00002428 · Cited by 52
Binding of the hypoxia tracer [3H]misonidazole in cerebral ischemia.
Hoffman, J. M., Rasey, J. S., Spence, A. M., Shaw, D., & Krohn, K. A. (1987) · Stroke · doi:10.1161/01.str.18.1.168 · Cited by 51
Manipulation and Exploitation of the Tumour Environment for Therapeutic Benefit
Stratford, I. J., ADAMS, G. E., Bremner, J. C. M., Cole, S., Edwards, H. S., Robertson, N., & Wood, P. J. (1994) · International Journal of Radiation Biology · doi:10.1080/09553009414550121 · Cited by 50
Targeting topoisomerase I to inhibit hypoxia inducible factor 1.
Rapisarda, A., Shoemaker, R. H., & Melillo, G. (2004) · PubMed · Cited by 49
Regional tumor oxygen dynamics: 19F PBSR EPI of hexafluorobenzene
Le, D., Mason, R. P., Hunjan, S., et al. (1997) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(97)00035-0 · Cited by 49
Is misonidazole binding to mouse tissues a measure of cellular pO2?
Os-corby, D. J. V., Koch, C. J., & Chapman, J. D. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90330-3 · Cited by 48
Zhao, D., Constantinescu, A., Hahn, E. W., & Mason, R. P. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)02822-5 · Cited by 48
Raghunand, N., & Gillies, R. J. (2001) · Novartis Foundation symposium · doi:10.1002/0470868716.ch14 · Cited by 47
Experimental Chemotherapy and Concepts Related to the Cell Cycle
Tannock, I. F. (1986) · International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine · doi:10.1080/09553008514552581 · Cited by 46
Magnetic resonance imaging of tumor vasculature
Chetrit-Dadiani, M., Bogin, L., Furman‐Haran, E., & Degani, H. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613539 · Cited by 45
Hill, R. P., Jaeger, K. D., Jang, A., & Cairns, R. A. (2001) · Novartis Foundation symposium · doi:10.1002/0470868716.ch11 · Cited by 45
Fluorocarbons as oxygen carriers. I. An NMR study of oxygen solutions in hexafluorobenzene
Delpuecha, J.-J., Hamza, M. A., Serratrice, G., & Stébé, M. (1979) · The Journal of Chemical Physics · doi:10.1063/1.437853 · Cited by 45
Schmiedl, U. P., Brasch, R. C., Ogan, M., & Moseley, M. E. (1990) · PubMed · Cited by 44
Haffty, B. G., Son, Y. H., Wilson, L. D., Papac, R. J., FISCHER, D. B., Rockwell, S., Sartorelli, A. C., Ross, D. A., Sasaki, C. T., & Fischer, J. J. (1997) · Radiation Oncology Investigations · doi:10.1002/(sici)1520-6823(1997)5:5<213::aid-roi1>3.0.co;2-0 · Cited by 44
Le, Q., Kovacs, M. S., Dorie, M. J., Koong, A. C., Terris, D. J., Pinto, H. A., Goffinet, D. R., Nowels, K. W., Bloch, D. A., & Brown, J. M. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04503-0 · Cited by 43
Vujaskovic, Z., Rosen, E. L., Blackwell, K. L., Jones, E. L., Brizel, D. M., Prosnitz, L. R., Samulski, T. V., & Dewhirst, M. W. (2003) · International Journal of Hyperthermia · doi:10.1080/0265673031000121517 · Cited by 42
He, Q., Xu, R. Z., Shkarin, P., Pizzorno, G., Lee-French, C. H., Rothman, D. L., Shungu, D. C., & Shim, H. (2004) · Disease Markers · doi:10.1155/2004/424395 · Cited by 42
Targeting Topoisomerase 1 to inhibit Hypoxia Inducible Factor 1
Rapisarda, A., Shoemaker, R. H., & Melillo, G. (2004) · Cell Cycle · doi:10.4161/cc.3.2.688 · Cited by 41
Self-citationShulman, L. N., Buswell, L. A., Riese, N. E., Doherty, N., Loeffler, J. S., Roemeling, R. W. V., & Coleman, C. N. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00016-4 · Cited by 40
O’Hara, J. A., Blumenthal, R. D., Grinberg, O. Y., Demidenko, E., Grinberg, S. A., Wilmot, C. M., Taylor, A., Goldenberg, D. M., & Swartz, H. M. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)155[0466:rtrcwt]2.0.co;2 · Cited by 38
Zagorevskii, D. V., Song, M., Breneman, C. M., Yuan, Y., Fuchs-Knotts, T., Gates, K. S., & Greenlief, C. M. (2003) · Journal of the American Society for Mass Spectrometry · doi:10.1016/s1044-0305(03)00334-9 · Cited by 38
Doll, C., Milosevic, M., Pintilie, M., Hill, R. P., & Fyles, A. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04474-7 · Cited by 37
Comparison between the comet assay and the oxygen microelectrode for measurement of tumor hypoxia
Aquino‐Parsons, C., Luo, C., Vikse, C. M., & Olive, P. L. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00035-3 · Cited by 35
Jette, D., Wiebe, L. I., Flanagan, R. J., Lee, J., & Chapman, J. D. (1986) · Radiation Research · doi:10.2307/3576542 · Cited by 34
Su, M., Wang, Z., & Nalcioglu, O. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199901)9:1<128::aid-jmri17>3.0.co;2-e · Cited by 34
Molecular imaging in prostate cancer
Karam, J. A., Mason, R. P., Koeneman, K. S., Antich, P. P., Benaim, E. A., & Hsieh, J. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10636 · Cited by 34
Acute Tumor Response to ZD6126 Assessed by Intrinsic Susceptibility Magnetic Resonance Imaging
Robinson, S. P., Kalber, T. L., Howe, F. A., McIntyre, D. J. O., Griffiths, J. R., Blakey, D. C., Whittaker, L., Ryan, A. J., & Waterton, J. C. (2005) · Neoplasia · doi:10.1593/neo.04622 · Cited by 34
In vivo EPR spectroscopy: biomedical and potential diagnostic applications
Jackson, S. K., Thomas, M. P., Smith, S. J., Madhani, M., Rogers, S. C., & James, P. E. (2003) · Faraday Discussions · doi:10.1039/b307162f · Cited by 33
Ravi, D., Ramadas, K., Mathew, B., Panikkar, K. R., Nair, M. K., & Pillai, M. R. (2001) · Oral Oncology · doi:10.1016/s1368-8375(00)00082-8 · Cited by 32
Vaupel, P. W., Thews, O., Kelleher, D. K., & Konerding, M. A. (2003) · International Journal of Oncology · doi:10.3892/ijo.22.4.795 · Cited by 32
Oxygenation of Mammary Tumors as Evaluated by Ultrasound-Guided Computerized-PO2-Histography
Runkel, S., Wischnik, A., Teubner, J., Kaven, E., Gaa, J., & Melchert, F. (1994) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2468-7_60 · Cited by 31
NEW MR IMAGING CONTRAST AGENTS
Earls, J. P., & Bluemke, D. A. (1999) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/s1064-9689(21)00021-0 · Cited by 30
Tumor Oximetry: Comparison of 19F MR EPI and Electrodes
Mason, R. P., Hunjan, S., Constantinescu, A., Song, Y., Zhao, D., Hahn, E. W., Antich, P. P., & Peschke, P. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0075-9_3 · Cited by 29
Mitochondrial dysfunction after aerobic exposure to the hypoxic cytotoxin tirapazamine.
Wouters, B. G., Delahoussaye, Y. M., Evans, J., Birrell, G. W., Dorie, M. J., Wang, J., MacDermed, D. M., Chiu, R. K., & Brown, J. M. (2001) · PubMed · Cited by 29
Schuster, D. P., Markham, J., & Welch, M. J. (1998) · Critical Care Medicine · doi:10.1097/00003246-199803000-00026 · Cited by 28
Head and Neck Cancer: The Importance of Oxygen
Terris, D. J. (2000) · The Laryngoscope · doi:10.1097/00005537-200005000-00001 · Cited by 28
Engelhardt, E. L., Schneider, R. F., Seeholzer, S. H., Stobbe, C. C., & Chapman, J. D. (2002) · PubMed · Cited by 28
Prediction of tumour hypoxia and radioresistance with nuclear medicine markers.
Chapman, J. D., Coia, L. R., Stobbe, C. C., Engelhardt, E. L., Fenning, M. C., & Schneider, R. F. (1996) · Europe PMC (PubMed Central) · Cited by 27
Increase of brain tumor oxygenation during cervical spinal cord stimulation: Report of three cases
Clavo, B., Robaina, F. J., Morera, J., Ruiz-Egea, E., Pérez, J. L., Macías, D., Caramés, M. Á., Catalá, L., Hernández, M. A., & Günderoth-Palmowski, M. (2002) · Journal of Neurosurgery Spine · doi:10.3171/spi.2002.96.1.0094 · Cited by 27
EPR oximetry of tumors in vivo in cancer therapy
Šentjurc, M., Čemažar, M., & Serša, G. (2004) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2003.10.036 · Cited by 26
Quantitative assessment of tumor oxygen dynamics: Molecular imaging for prognostic radiology
Mason, R. P., Ran, S., & Thorpe, P. E. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10404 · Cited by 26
Interstitial Fluid Pressure in Cervical Cancer
Milosevic, M., Fyles, A., & Hill, R. P. (2001) · American Journal of Clinical Oncology · doi:10.1097/00000421-200110000-00020 · Cited by 26
Small Molecule-Mediated Anti-Cancer Therapy via Hypoxia Inducible Factor-1 Blockade
Macpherson, G. R., & Figg, W. D. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.6.961 · Cited by 24
Direct Measurement of the PO2 Distribution in Human Malignant Brain Tumours
Cruickshank, G., Rampling, R. P., & Cowans, W. (1994) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2468-7_62 · Cited by 24
Dynamic Breast Tumor Oximetry: The Development of Prognostic Radiology
Song, Y., Constantinescu, A., & Mason, R. P. (2002) · Technology in Cancer Research & Treatment · doi:10.1177/153303460200100607 · Cited by 23
Intraoperative radiotherapy for primary and recurrent rectal cancer
Kallinowski, F., Eble, M. J., Buhr, H., et al. (1995) · European Journal of Surgical Oncology · doi:10.1016/s0748-7983(95)90501-4 · Cited by 23
Yamada, K., Inoue, D., Matsumoto, S., & Utsumi, H. (2004) · Antioxidants and Redox Signaling · doi:10.1089/152308604773934369 · Cited by 22
Mannan, R., Mercer, J. R., Wiebe, L. I., Kumar, P., Somayaji, V. V., & Chapman, J. D. (1992) · PubMed · Cited by 18
Tissue oxygenation in sepsis; new insights from in vivo EPR
James, P. E., Thomas, M. P., & Jackson, S. K. (2004) · NMR in Biomedicine · doi:10.1002/nbm.910 · Cited by 11
The Difficulties in Comparing In Vivo Oxygen Measurements: Turning the problems into virtues
Swartz, H. M., & Dunn, J. F. (2005) · Advances in experimental medicine and biology · doi:10.1007/0-387-26206-7_39 · Cited by 9
Quiescent Hypervascularity Mediated by Gain of HIF-1 FunctionPreprint
Arbeit, J. M. (2002) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2002.67.133 · Cited by 7
Cited by
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116
Hypoxia, DNA repair and genetic instability
Bristow, R. G., & Hill, R. P. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2344 · Cited by 1,140
Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
McKeown, S. R. (2014) · The British Journal of Radiology · doi:10.1259/bjr.20130676 · Cited by 1,050
Metadata
- Authors
- Tatum, J. L.
- Venue
- International Journal of Radiation Biology
- Publisher
- Informa UK Limited
- Published
- 2006-01
- Volume
- 82
- Issue
- 10
- Pages
- 699-757
- ISSN
- 0955-3002 (ISSN-L)
- 1362-3095
- OpenAlex
- W2116263694
- Cited by
- 620
- References
- 283
- FWCI
- 13.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.